CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies
AbstractTetraspanins are integral transmembrane proteins organized in microdomains displaying specific and direct interactions with other tetraspanins and molecular partners. Among them, CD81 has been implicated in a variety of physiological and pathological processes. CD81 also plays a crucial role in pathogen entry into host cells, including hepatitis C virus (HCV) entry into hepatocytes. HCV is a major cause of liver cirrhosis and hepatocellular carcinoma. HCV entry into hepatocytes is a complex process that requires the coordinated interaction of viral and host factors for the initiation of infection, including CD81, scavenger receptor BI, claudin-1, occludin, membrane-bound host cell kinases, Niemann-Pick C1 Like 1, Harvey rat sarcoma viral oncogene homolog (HRas), CD63 and transferrin receptor 1. Furthermore, recent data in HCV model systems have demonstrated that targeting critical components of tetraspanins and associated cell membrane proteins open new avenues to prevent and treat viral infection.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Zona, L.; Tawar, R.G.; Zeisel, M.B.; Xiao, F.; Schuster, C.; Lupberger, J.; Baumert, T.F. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses 2014, 6, 875-892.
Zona L, Tawar RG, Zeisel MB, Xiao F, Schuster C, Lupberger J, Baumert TF. CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies. Viruses. 2014; 6(2):875-892.Chicago/Turabian Style
Zona, Laetitia; Tawar, Rajiv G.; Zeisel, Mirjam B.; Xiao, Fei; Schuster, Catherine; Lupberger, Joachim; Baumert, Thomas F. 2014. "CD81-Receptor Associations — Impact for Hepatitis C Virus Entry and Antiviral Therapies." Viruses 6, no. 2: 875-892.